A patient with recalcitrant oral pemphigus vulgaris successfully treated with a biologic drug- Rituximab
Pemphigus vulgaris (PV) is a chronic autoimmune blistering disease affecting mucous membranes and the skin. Rituximab (RTX), a monoclonal antibody against CD20, has been approved by FDA for the treatment of adults with moderate to severe PV. A 42-year-old Indian woman, previously diagnosed with oral...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Online |
| Språk: | engelska |
| Publicerad: |
International Association for Dental Research (Nigeria Division)
2019
|
| Länkar: | https://ajoh.oauife.edu.ng/index.php/ajoh/article/view/41 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|